HIF1A and non-small cell lung carcinoma: This is consistent with our recent findings in NSCLC, in which the combination of hypoxia and activation of the tyrosine kinase receptor, EGFR, led to additive or synergistic up-regulation of CXCR4 expression via HIF-1α [35].